Hello tutor, please help with the following The INNOVA programme offers the researchers a wide range of tools to start or reinforce agreements with the private sector. For this reason, researchers represent the key factor of the success of the programme with their capacity to develop and maintain longterm relationships and to introduce new research groups to their business contacts considered vital.

161 Can pyramidal tract lesions present as false localizing signs in benign intracranial hypertension?

162 How often can increased intracranial hypertension be present without papilloedema on examination?

163 Which is the most effective method of reducing raised intracranial pressure: mannitol, steroids or ventilation?

164 In the case of pseudotumour cerebri, if this is proved to be due to sagittal sinus thrombosis with no explanation for the thrombosis, should the patient receive lifelong anticoagulation treatment?

165 Does digitalis help reduce cerebrospinal fluid (CSF) formation, specifically in the treatment of resistant benign intracranial hypertension?

166 Is it safe to combine hydrochlorothiazide, amiloride, acetazolamide and digitalis (125 g per day) in a hypertensive patient with idiopathic intracranial hypertension (pseudotumour cerebri)?

167 What is the best indicator for monitoring the efficacy of treatment or the progress of the disease in pseudotumor cerebri? Is it by the disappearance of papilloedema, the relief of headache or by frequent visual field examination or cerebrospinal fluid (CSF) pressure?

168 What is the definition of 'bursting' when describing a headache?

169 1. What drugs, other than tricyclic antidepressants, can be used in prophylaxis for daily tension headache? 2. Is propranolol an effective treatment?

170 Are maprotiline and imipramine as effective as amitriptyline in the treatment of tension headache?